Dimitris Kalles
Overview
Explore the profile of Dimitris Kalles including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
172
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kreouzi M, Theodorakis N, Feretzakis G, Paxinou E, Sakagianni A, Kalles D, et al.
Cancers (Basel)
. 2025 Jan;
17(1.
PMID: 39796659
: Melanoma, an aggressive form of skin cancer, accounts for a significant proportion of skin-cancer-related deaths worldwide. Early and accurate differentiation between melanoma and benign melanocytic nevi is critical for...
2.
Sakagianni A, Koufopoulou C, Koufopoulos P, Kalantzi S, Theodorakis N, Nikolaou M, et al.
Antibiotics (Basel)
. 2024 Nov;
13(11).
PMID: 39596745
The emergence of antimicrobial resistance (AMR) due to the misuse and overuse of antibiotics has become a critical threat to global public health. There is a dire need to forecast...
3.
Feretzakis G, Anastasiou A, Pitoglou S, Paxinou E, Gkoulalas-Divanis A, Kalodanis K, et al.
Stud Health Technol Inform
. 2024 Nov;
321:195-199.
PMID: 39575807
In Generative Artificial Intelligence (AI), Large Language Models (LLMs) like GPT-4, Gemini, Claude, and Llama, significantly impact healthcare by aiding in patient care, medical research, and administrative tasks. AI-powered chatbots...
4.
Feretzakis G, Anastasiou A, Pitoglou S, Sakagianni A, Rakopoulou Z, Kalodanis K, et al.
Stud Health Technol Inform
. 2024 Nov;
321:84-88.
PMID: 39575785
This study leverages the DCTPep database, a comprehensive repository of cancer therapy peptides, to explore the application of machine learning in accelerating cancer research. We applied Principal Component Analysis (PCA)...
5.
Sakagianni A, Koufopoulou C, Koufopoulos P, Feretzakis G, Kalles D, Paxinou E, et al.
Antibiotics (Basel)
. 2024 Oct;
13(10).
PMID: 39452262
Background/objectives: Carbapenem resistance poses a significant threat to public health by undermining the efficacy of one of the last lines of antibiotic defense. Addressing this challenge requires innovative approaches that...
6.
Feretzakis G, Theodorakis N, Vamvakou G, Hitas C, Anagnostou D, Kalantzi S, et al.
Stud Health Technol Inform
. 2024 Aug;
316:868-872.
PMID: 39176930
This study investigates the forecasting of cardiovascular mortality trends in Greece's elderly population. Utilizing mortality data from 2001 to 2020, we employ two forecasting models: the Autoregressive Integrated Moving Average...
7.
Triantafyllopoulos L, Feretzakis G, Tzelves L, Sakagianni A, Verykios V, Kalles D
Stud Health Technol Inform
. 2024 Aug;
316:535-539.
PMID: 39176797
In an era increasingly focused on integrating Artificial Intelligence (AI) into healthcare, the utility and user satisfaction of AI applications like ChatGPT have become pivotal research areas. This study, conducted...
8.
Feretzakis G, Dalamarinis K, Kalles D, Kiourt C, Pantos G, Papadopoulos I, et al.
Stud Health Technol Inform
. 2024 Aug;
316:1184-1188.
PMID: 39176593
The intersection of COVID-19 and pulmonary embolism (PE) has posed unprecedented challenges in medical diagnostics. The critical nature of PE and its increased incidence during the pandemic underline the need...
9.
Manolitsis I, Feretzakis G, Tzelves L, Kalles D, Katsimperis S, Angelopoulos P, et al.
Stud Health Technol Inform
. 2023 Jun;
305:576-579.
PMID: 37387096
Artificial Intelligence (AI) has shown the ability to enhance the accuracy and efficiency of physicians. ChatGPT is an AI chatbot that can interact with humans through text, over the internet....
10.
Manolitsis I, Tzelves L, Feretzakis G, Kalles D, Verykios V, Katsimperis S, et al.
Stud Health Technol Inform
. 2023 Jun;
305:572-575.
PMID: 37387095
ASCAPE Project is a study aiming to implement the advances of Artificial Intelligence (AI), to support prostate cancer survivors, regarding quality of life issues. The aim of the study is...